Literature DB >> 20309833

[Inflammation as a therapeutic agent in cerebral infarction: cellular inflammatory response and inflammatory mediators].

María D Cuenca-López1, David Brea, Tomás Segura, María F Galindo, David Antón-Martínez, Jesús Agulla, José Castillo, Joaquín Jordán.   

Abstract

INTRODUCTION: The immune central nervous system (CNS) innate immune cells including microglia and macrophages play integral roles in receiving and propagating inflammatory signals. Inflammation is generally a beneficial response of an organism to infection but, when prolonged or inappropriate, it can be detrimental. Neuronal loss in acute (e.g. stroke and head injury) and chronic (e.g. multiple sclerosis and Alzheimer's disease) CNS diseases has been associated with inflammatory processes systemically and in the brain. DEVELOPMENT: Herein we review the processes that participate in the activation of the immune system and the starting of inflammatory response after stroke, where neuronal necrotic cell death has been described. We addressed the relevance of the innate inflammatory cells that are on the CNS, as microglia and macrophages, which have an important role in receiving and spreading inflammatory signals. In addition, the inflammatory response is characterized by an increase in the levels of expression of inflammatory mediators, which regulate adhesion molecules, and increase the permeability of the blood-brain barrier. It has also been described that inflammation promotes the rapid over-expression and activation of a variety of genes, and it has been postulated that transcription factors should be studied for their potential use in therapeutics and repair. Transcriptional activation can be a double-edged sword since depending on the individual transcription factor it can induce the expression of either neuroprotective or neurotoxic genes.
CONCLUSION: In summary, a better understanding of the different molecules mediating the immune response will allow the design of new pharmacological tools that could improve stroke treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20309833

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  5 in total

1.  Baseline anticholinergic burden from medications predicts incident fatal and non-fatal stroke in the EPIC-Norfolk general population.

Authors:  David T Gamble; Allan B Clark; Robert N Luben; Nicholas J Wareham; Kay-Tee Khaw; Phyo K Myint
Journal:  Int J Epidemiol       Date:  2018-04-01       Impact factor: 7.196

2.  Correlation analysis between serum procalcitonin and infarct volume in young patients with acute cerebral infarction.

Authors:  Huijun Wen; Maikou Lv
Journal:  Neurol Sci       Date:  2020-10-27       Impact factor: 3.307

3.  Neuroprotective effect of Cerebralcare Granule after cerebral ischemia/reperfusion injury.

Authors:  Xiao-Xiao Zhang; Fen-Fen He; Gui-Lin Yan; Ha-Ni Li; Dan Li; Yan-Ling Ma; Fang Wang; Nan Xu; Fei Cao
Journal:  Neural Regen Res       Date:  2016-04       Impact factor: 5.135

4.  Electroacupuncture regulates the stress-injury-repair chain of events after cerebral ischemia/reperfusion injury.

Authors:  Peng Shi; Lin-Lin Sun; Yi-Shuo Lee; Ya Tu
Journal:  Neural Regen Res       Date:  2017-06       Impact factor: 5.135

Review 5.  Genetic Aspects of Inflammation and Immune Response in Stroke.

Authors:  Dejan Nikolic; Milena Jankovic; Bojana Petrovic; Ivana Novakovic
Journal:  Int J Mol Sci       Date:  2020-10-08       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.